<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To show a possible association between <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> and the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) in patients with <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Serum samples obtained from 88 children with various forms of juvenile <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic disease</z:e> and from 40 adults with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, or other <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic disease</z:e>, who had previously been tested and shown to be positive for IgG aPL, were analyzed for the presence of B19 DNA, for antibodies against the B19 <z:mp ids='MP_0001799'>viral</z:mp> proteins VP1, VP2, and NS1, and for IgG aPL (anticardiolipin, anti-beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I, and antiphosphatidylserine) </plain></SENT>
<SENT sid="2" pm="."><plain>As controls, serum samples obtained from 135 children with noninflammatory <z:e sem="disease" ids="C0005940" disease_type="Disease or Syndrome" abbrv="">bone diseases</z:e> or <z:hpo ids='HP_0001510'>growth retardation</z:hpo> were also analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Twenty-four (27%) of the 88 children with <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic diseases</z:e> had detectable amounts of IgG aPL </plain></SENT>
<SENT sid="4" pm="."><plain>Fourteen (58%) of these 24 IgG aPL-positive patients showed IgG against VP1/VP2 and <z:mp ids='MP_0001799'>viral</z:mp> genomes, indicating the presence of <z:hpo ids='HP_0011009'>acute</z:hpo> (2 patients) or persistent (12 patients) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Past <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> was identified in 7 (29%) of 24 IgG aPL-positive children, as indicated by VP1/VP2-specific IgG in the absence of <z:mp ids='MP_0001799'>viral</z:mp> DNA </plain></SENT>
<SENT sid="6" pm="."><plain>Three (12%) of 24 IgG aPL-positive children had not been infected with B19 </plain></SENT>
<SENT sid="7" pm="."><plain>Sixty-nine (51%) of 135 control children displayed VP1/VP2-specific IgG </plain></SENT>
<SENT sid="8" pm="."><plain>Three (2%) of these 135 children were IgG aPL positive (2 children had past <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e>, and 1 was negative for parvovirus B19) </plain></SENT>
<SENT sid="9" pm="."><plain>Analysis of the parvovirus B19 status of 40 adult IgG aPL-positive patients showed that 33 (83%) were anti-IgG VP1/VP2-positive, and <z:mp ids='MP_0001799'>viral</z:mp> DNA was detected in 11 patients (28%) </plain></SENT>
<SENT sid="10" pm="."><plain>Ten of these 11 viremic patients were in the subgroup of 28 IgG aPL-positive SLE patients </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are preferentially found in serum of children with juvenile idiopathic <z:hpo ids='HP_0001369'>arthritis</z:hpo> who have been previously infected with parvovirus B19 and have established, <z:e sem="disease" ids="C1264606" disease_type="Disease or Syndrome" abbrv="">persistent infection</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Adult patients with IgG aPL positivity have a high incidence of persistent <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>We conclude that parvovirus B19 might be directly involved in the elicitation of autoimmune reactions partly mediated by aPL </plain></SENT>
</text></document>